Literature DB >> 3488297

Uveoretinitis and pinealitis induced by immunization with interphotoreceptor retinoid-binding protein.

I Gery, B Wiggert, T M Redmond, T Kuwabara, M A Crawford, B P Vistica, G J Chader.   

Abstract

Rats immunized with microgram amounts of interphotoreceptor retinoid-binding protein (IRBP), a glycoprotein which localizes specifically in the eye and pineal gland, developed uveoretinitis and pinealitis. The severity and onset of changes were found to be dose-related and to be enhanced by B. pertussis bacteria. In general, the inflammatory changes induced by IRBP resembled those provoked by S-antigen (S-Ag), but significant differences were noted between the two diseases. The possible usefulness of the new experimental autoimmune disease is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3488297

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  32 in total

Review 1.  Sympathetic ophthalmia: an autoimmune ocular inflammatory disease.

Authors:  C C Chan; M Mochizuki
Journal:  Springer Semin Immunopathol       Date:  1999

2.  A novel inflammatory eye disease induced by lymphocytes from knockout mice sensitized against the deleted ocular antigen.

Authors:  M P Gelderman; P Charukamnoetkanok; J P Brady; L Hung; J S Zigler; E F Wawrousek; B P Vistica; E Fortin; C-C Chan; I Gery
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

3.  Apoptosis of CD4+ T cells occurs in experimental autoimmune anterior uveitis (EAAU).

Authors:  H G Yu; H Chung; W J Lee
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

4.  The matrix metalloproteinase inhibitor BB-1101 prevents experimental autoimmune uveoretinitis (EAU).

Authors:  G R Wallace; R A Whiston; M R Stanford; G M Wells; A J Gearing; J M Clements
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

5.  The expression of class I major histocompatibility antigens by human retinal pigment epithelium in vitro.

Authors:  M T Benson; L Shepherd; D Cottam; J Lawry; R C Rees; I G Rennie
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

6.  Ocular immune privilege in the year 2010: ocular immune privilege and uveitis.

Authors:  Andrew W Taylor; Henry J Kaplan
Journal:  Ocul Immunol Inflamm       Date:  2010-12       Impact factor: 3.070

Review 7.  Gut microbiota as a source of a surrogate antigen that triggers autoimmunity in an immune privileged site.

Authors:  Carlos R Zárate-Bladés; Reiko Horai; Mary J Mattapallil; Nadim J Ajami; Matthew Wong; Joseph F Petrosino; Kikuji Itoh; Chi-Chao Chan; Rachel R Caspi
Journal:  Gut Microbes       Date:  2017-01-03

8.  Understanding autoimmune uveitis through animal models. The Friedenwald Lecture.

Authors:  Rachel R Caspi
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

Review 9.  Immunopathology of uveitis.

Authors:  C C Chan; Q Li
Journal:  Br J Ophthalmol       Date:  1998-01       Impact factor: 4.638

Review 10.  Biologic agents in experimental autoimmune uveitis.

Authors:  Gian Paolo Giuliari; Ama Sadaka; David M Hinkle
Journal:  Int Ophthalmol       Date:  2013-03-14       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.